Inhibitory effect of 2-O-octadecylascorbic acid in agglutination assay with concanavalin A; short-term examination of rat urinary bladder carcinogenesis

Jpn J Cancer Res. 1991 Apr;82(4):386-9. doi: 10.1111/j.1349-7006.1991.tb01860.x.

Abstract

A derivative of ascorbic acid, 2-O-octadecylascorbic acid (CV-3611), is a strong scavenger of active oxygen species. We examined the effect of CV-3611 on a short-term test of bladder carcinogenesis, using concanavalin A (Con A)-dependent agglutination of isolated bladder epithelial cells. Rats were given 0.01% N-butyl-N-(4-hydroxybutyl)nitrosamine (BHBN) for 1 week, and then 5% sodium saccharin or 2% DL-tryptophan or 0.01% BHBN alone or with 0.002, 0.006 or 0.02% CV-3611 for 3 weeks. Treatment with CV-3611 reduced the effects of the bladder tumor promoters sodium saccharin and DL-tryptophan by 48-86 and 65-87%, respectively. CV-3611 also reduced the number of aggregates of bladder epithelial cells from rats treated with BHBN for 4 weeks. These results suggest that CV-3611 has a suppressive effect on rat bladder carcinogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Agglutination Tests
  • Animals
  • Ascorbic Acid / analogs & derivatives*
  • Ascorbic Acid / pharmacology
  • Ascorbic Acid / therapeutic use
  • Butylhydroxybutylnitrosamine
  • Cell Aggregation / drug effects*
  • Concanavalin A
  • Free Radical Scavengers*
  • Male
  • Rats
  • Saccharin
  • Tryptophan
  • Urinary Bladder Neoplasms / chemically induced*
  • Urinary Bladder Neoplasms / drug therapy

Substances

  • Free Radical Scavengers
  • Concanavalin A
  • Butylhydroxybutylnitrosamine
  • Tryptophan
  • 2-O-octadecylascorbic acid
  • Saccharin
  • Ascorbic Acid